NCT00290602View on ClinicalTrials.gov

Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

December 31, 2006

Conditions
Acute Respiratory Distress SyndromeAcute Lung InjuryPostoperative Complications
Interventions
DRUG

Methylprednisolone sodium succinate

Trial Locations (1)

411-769

National Cancer Center, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT00290602 - Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter